Cancer outcomes and cardiopulmonary toxicities for Black patients with breast cancer treated with proton therapy
Open Access
- 28 December 2024
- journal article
- Published by Oxford University Press (OUP) in JNCI Cancer Spectrum
- Vol. 9 (1)
Abstract
Background: Black women have a 40% higher breast cancer mortality rate than White women and are at a higher risk of acquiring cardiovascular disease. Proton therapy can be used to mitigate cardiac radiation exposure; however, proton therapy remains a scarce resource in the United States. We report on the cardiovascular profiles of patients undergoing proton therapy to determine the potential benefit of the therapy for Black women compared with patients of other races. Methods: We retrospectively analyzed 599 patients with breast cancer who received proton therapy from June 2016 to December 2021 at the Maryland Proton Treatment Center. A variety of sociodemographic, disease, and treatment variables were analyzed using descriptive statistics. Results: With a median follow-up of 26 months (range = 0.47-90 months), Black patients made up 31.6% of the population and presented with higher rates of hypertension (P < .001), cardiopulmonary conditions (P < .001), and a higher median body mass index (P = .015) compared with the other cohort, a trend that persisted at the time of post–proton therapy follow-up. Black women had higher rates of triple-negative disease (P < .001), with subsequent greater receipt of neoadjuvant chemotherapy (P = .039). Pulmonary events were 2.6 times more likely to occur in Black patients than in the non-Black cohort after proton therapy (odds ratio = 2.60, 95% CI = 1.39 to 4.88; P = .003). Conclusions: Black women presenting for proton therapy had higher baseline risks of cardiovascular co-morbidities combined with more aggressive breast cancer biology and a subsequent 2.6-fold increased risk of pulmonary events after proton therapy. Our findings support the use of advanced radiation techniques as a means of sparing important organs at risk, especially in historically marginalized populations.Keywords
This publication has 55 references indexed in Scilit:
- Cardiac dose in the treatment of synchronous bilateral breast cancer patients between three different radiotherapy techniques (VMAT, IMRT, and 3D CRT)Discover Oncology, 2023
- “There's not enough studies”: Views of black breast and ovarian cancer patients on research participationCancer Medicine, 2023
- Association of Race With Receipt of Proton Beam Therapy for Patients With Newly Diagnosed Cancer in the US, 2004-2018JAMA Network Open, 2022
- Comorbidities and the risk of cardiovascular disease mortality among racially diverse patients with breast cancerCancer, 2021
- Association of Left Anterior Descending Coronary Artery Radiation Dose With Major Adverse Cardiac Events and Mortality in Patients With Non–Small Cell Lung CancerJAMA Oncology, 2021
- Disparities in Cardiovascular Care and Outcomes for Women From Racial/Ethnic Minority BackgroundsCurrent Treatment Options in Cardiovascular Medicine, 2020
- Associations between breast cancer subtype and neighborhood socioeconomic and racial composition among Black and White womenBreast Cancer Research and Treatment, 2020
- Anthracycline Chemotherapy and CardiotoxicityCardiovascular Drugs and Therapy, 2017
- Delayed Initiation of Adjuvant Chemotherapy Among Patients With Breast CancerJAMA Oncology, 2016
- The association of race/ethnicity, insurance status, and socioeconomic factors with breast cancer careCancer, 2010